Literature DB >> 10618408

Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor.

P Bousso1, V Wahn, I Douagi, G Horneff, C Pannetier, F Le Deist, F Zepp, T Niehues, P Kourilsky, A Fischer, G de Saint Basile.   

Abstract

In this report, we have analyzed the human T cell repertoire derived in vivo from a single T cell precursor. A unique case of X-linked severe combined immunodeficiency in which a reverse mutation occurred in an early T cell precursor was analyzed to this end. It was determined that at least 1,000 T cell clones with unique T cell receptor-beta sequences were generated from this precursor. This diversity seems to be stable over time and provides protection from infections in vivo. A similar estimation was obtained in an in vitro murine model of T cell generation from a single cell precursor. Overall, our results document the large diversity potential of T cell precursors and provide a rationale for gene therapy of the block of T cell development.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618408      PMCID: PMC26653          DOI: 10.1073/pnas.97.1.274

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  A direct estimate of the human alphabeta T cell receptor diversity.

Authors:  T P Arstila; A Casrouge; V Baron; J Even; J Kanellopoulos; P Kourilsky
Journal:  Science       Date:  1999-10-29       Impact factor: 47.728

2.  Bcl-2 rescues T lymphopoiesis, but not B or NK cell development, in common gamma chain-deficient mice.

Authors:  M Kondo; K Akashi; J Domen; K Sugamura; I L Weissman
Journal:  Immunity       Date:  1997-07       Impact factor: 31.745

3.  A molecular map of T cell development.

Authors:  D B Sant'Angelo; B Lucas; P G Waterbury; B Cohen; T Brabb; J Goverman; R N Germain; C A Janeway
Journal:  Immunity       Date:  1998-08       Impact factor: 31.745

Review 4.  A very high level of crossreactivity is an essential feature of the T-cell receptor.

Authors:  D Mason
Journal:  Immunol Today       Date:  1998-09

5.  Development of T cell precursor activity in the murine fetal liver.

Authors:  H Ema; I Douagi; A Cumano; P Kourilsky
Journal:  Eur J Immunol       Date:  1998-05       Impact factor: 5.532

6.  Effect of deoxyguanosine on lymphopoiesis in the developing thymus rudiment in vitro: application in the production of chimeric thymus rudiments.

Authors:  E J Jenkinson; L L Franchi; R Kingston; J J Owen
Journal:  Eur J Immunol       Date:  1982-07       Impact factor: 5.532

Review 7.  Multiple gamma c-dependent cytokines regulate T-cell development.

Authors:  T R Malek; B O Porter; Y W He
Journal:  Immunol Today       Date:  1999-02

8.  Designing and maintaining the mature TCR repertoire: the continuum of self-peptide:self-MHC complex recognition.

Authors:  C Viret; F S Wong; C A Janeway
Journal:  Immunity       Date:  1999-05       Impact factor: 31.745

9.  The composition of a primary T cell response is largely determined by the timing of recruitment of individual T cell clones.

Authors:  P Bousso; J P Levraud; P Kourilsky; J P Abastado
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

10.  Phenotypic and functional separation of memory and effector human CD8+ T cells.

Authors:  D Hamann; P A Baars; M H Rep; B Hooibrink; S R Kerkhof-Garde; M R Klein; R A van Lier
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

View more
  43 in total

Review 1.  Severe combined immunodeficiencies (SCID).

Authors:  A Fischer
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

Review 2.  Gene therapy of X-linked severe combined immunodeficiency.

Authors:  Salima Hacein-Bey-Abina; Alain Fischer; Marina Cavazzana-Calvo
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

3.  20 years of gene therapy for SCID.

Authors:  Alain Fischer; Salima Hacein-Bey-Abina; Marina Cavazzana-Calvo
Journal:  Nat Immunol       Date:  2010-06       Impact factor: 25.606

4.  Somatic mosaicism in Wiskott--Aldrich syndrome suggests in vivo reversion by a DNA slippage mechanism.

Authors:  T Wada; S H Schurman; M Otsu; E K Garabedian; H D Ochs; D L Nelson; F Candotti
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-10       Impact factor: 11.205

5.  Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease.

Authors:  Christian M Brommel; Ashley L Cooney; Patrick L Sinn
Journal:  Hum Gene Ther       Date:  2020-08-21       Impact factor: 5.695

Review 6.  Survival of the fittest: in vivo selection and stem cell gene therapy.

Authors:  Tobias Neff; Brian C Beard; Hans-Peter Kiem
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

7.  Optimized transduction of canine paediatric CD34(+) cells using an MSCV-based bicistronic vector.

Authors:  S E Suter; T A Gouthro; P A McSweeney; R A Nash; M E Haskins; P J Felsburg; P S Henthorn
Journal:  Vet Res Commun       Date:  2006-11       Impact factor: 2.459

Review 8.  Update on clinical gene therapy in childhood.

Authors:  Waseem Qasim; H Bobby Gaspar; Adrian J Thrasher
Journal:  Arch Dis Child       Date:  2007-11       Impact factor: 3.791

9.  Comprehensive assessment of T-cell receptor beta-chain diversity in alphabeta T cells.

Authors:  Harlan S Robins; Paulo V Campregher; Santosh K Srivastava; Abigail Wacher; Cameron J Turtle; Orsalem Kahsai; Stanley R Riddell; Edus H Warren; Christopher S Carlson
Journal:  Blood       Date:  2009-08-25       Impact factor: 22.113

10.  In vivo correction of ZAP-70 immunodeficiency by intrathymic gene transfer.

Authors:  Oumeya Adjali; Gilles Marodon; Marcos Steinberg; Cédric Mongellaz; Véronique Thomas-Vaslin; Chantal Jacquet; Naomi Taylor; David Klatzmann
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.